Cited by

• Reversal of the reserpine-induced ptosis by L-threo-3,4-dihydroxy-phenylserine (L-threo-DOPS), a (-)-norepinephrine precursor, and its potentiation by imipramine or nialamide.

  Kato T, Katsuyama M, Karai N, Hirose A, Nakamura M, Katsube J. Kato T, et al. Naunyn Schmiedebergs Arch Pharmacol. 1986 Mar;332(3):243-6. doi: 10.1007/BF00504861. Naunyn Schmiedebergs Arch Pharmacol. 1986. PMID: 3086752
• [Evaluation of central antireserpine effect by the use of light blink reflex (author's transl)].

  Dupeyron JP, Boulu R, Rossignol P. Dupeyron JP, et al. Psychopharmacologia. 1973 Oct 23;33(1):87-94. doi: 10.1007/BF00428796. Psychopharmacologia. 1973. PMID: 4769025 French. No abstract available.
• Doxepin up-to-date: a review of its pharmacological properties and therapeutic efficacy with particular reference to depression.

  Pinder RM, Brogden RN, Speight TM, Avery GS. Pinder RM, et al. Drugs. 1977 Mar;13(3):161-218. doi: 10.2165/00003495-197713030-00001. Drugs. 1977. PMID: 321205 Review.
• Close correlation between behavioural response and binding in vivo for inhibitors of the rolipram-sensitive phosphodiesterase.

  Schmiechen R, Schneider HH, Wachtel H. Schmiechen R, et al. Psychopharmacology (Berl). 1990;102(1):17-20. doi: 10.1007/BF02245738. Psychopharmacology (Berl). 1990. PMID: 2392503
• Effect of drugs in adaptation in heat and cold.

  Weihe WH. Weihe WH. Int J Biometeorol. 1976;6(2 Suppl):125-36. doi: 10.1007/BF01553969. Int J Biometeorol. 1976. PMID: 992888 No abstract available.